COVID-19-associated anorexia

Jump to navigation Jump to search

For COVID-19 frequently asked outpatient questions, click here
For COVID-19 frequently asked inpatient questions, click here

WikiDoc Resources for COVID-19-associated anorexia

Articles

Most recent articles on COVID-19-associated anorexia

Most cited articles on COVID-19-associated anorexia

Review articles on COVID-19-associated anorexia

Articles on COVID-19-associated anorexia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on COVID-19-associated anorexia

Images of COVID-19-associated anorexia

Photos of COVID-19-associated anorexia

Podcasts & MP3s on COVID-19-associated anorexia

Videos on COVID-19-associated anorexia

Evidence Based Medicine

Cochrane Collaboration on COVID-19-associated anorexia

Bandolier on COVID-19-associated anorexia

TRIP on COVID-19-associated anorexia

Clinical Trials

Ongoing Trials on COVID-19-associated anorexia at Clinical Trials.gov

Trial results on COVID-19-associated anorexia

Clinical Trials on COVID-19-associated anorexia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on COVID-19-associated anorexia

NICE Guidance on COVID-19-associated anorexia

NHS PRODIGY Guidance

FDA on COVID-19-associated anorexia

CDC on COVID-19-associated anorexia

Books

Books on COVID-19-associated anorexia

News

COVID-19-associated anorexia in the news

Be alerted to news on COVID-19-associated anorexia

News trends on COVID-19-associated anorexia

Commentary

Blogs on COVID-19-associated anorexia

Definitions

Definitions of COVID-19-associated anorexia

Patient Resources / Community

Patient resources on COVID-19-associated anorexia

Discussion groups on COVID-19-associated anorexia

Patient Handouts on COVID-19-associated anorexia

Directions to Hospitals Treating COVID-19-associated anorexia

Risk calculators and risk factors for COVID-19-associated anorexia

Healthcare Provider Resources

Symptoms of COVID-19-associated anorexia

Causes & Risk Factors for COVID-19-associated anorexia

Diagnostic studies for COVID-19-associated anorexia

Treatment of COVID-19-associated anorexia

Continuing Medical Education (CME)

CME Programs on COVID-19-associated anorexia

International

COVID-19-associated anorexia en Espanol

COVID-19-associated anorexia en Francais

Business

COVID-19-associated anorexia in the Marketplace

Patents on COVID-19-associated anorexia

Experimental / Informatics

List of terms related to COVID-19-associated anorexia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Javaria Anwer M.D.[2]

Synonyms and keywords:COVID-19 associated loss of appetite, COVID-19 and hunger, appetite and COVID-19, loss of appetite in COVID, COVID and hunger, SARS-Cov-2 associated anorexia, SARS-Cov-2 associated loss of appetite, SARS CoV2 and hunger, Coronavirus and hunger, appetite and COVID-19, covid19 associated anorexia.

Overview

COVID-19 is primarily known to be a respiratory disease. Anorexia associated with COVID-19 is the most common digestive symptom among patients with COVID-19. The exact mechanism of loss of appetite associated with the infection is unknown, but the symptom may be due to various causes. Several diseases share loss of appetite symptom, so it is important to suspect COVID-19 and perform RT-PCR to detect the infection or CXR to detect possible lung manifestations. Patients with loss of appetite may present with associated symptoms such as nausea or vomiting and diarrhea. The mainstay of treatment in COVID-19 infection is supportive therapy and antiviral therapy. Hand hygiene and social distancing are important primary prevention tools. Contact tracing is an important tool of secondary prevention.

Historical Perspective

  • COVID-19 was first discovered in Wuhan, China. On 30th December 2019, three bronchoalveolar lavage samples were collected from a patient with pneumonia of unknown etiology – a surveillance definition established following the SARS outbreak of 2002-2003 – in Wuhan Jinyintan Hospital. Real-time PCR (RT-PCR) assays on these samples were positive for pan-Betacoronavirus.[1]
  • Nanopore sequencing and bioinformatic analyses indicated that the virus had features typical of the coronavirus family and belonged to the Betacoronavirus 2B lineage.[1]
  • COVID-19 was primarily known as a respiratory disease. In the initial reports from the World Health Organization (WHO), the mode of transmission of COVID-19 was reported to spread through droplets and fomites during close unprotected contact between an infector and an infectee. Airborne transmission was not reported initially.
  • Fecal shedding was demonstrated from patients, with viable virus identified in a limited number of case reports. However, fecal-oral route did not appear to drive COVID-19 transmission.[1][2]
  • COVID-19 associated anorexia was first described as one of the less common symptoms of COVID-19 in a retrospective, single-center case series by Wang D et al. published on Feb 7th, 2020. The patient data was derived from January 1st-Jan 28th,2020 at Zhongnan Hospital in Wuhan, China.[3]
  • COVID-19 associated anorexia was not only described as one of the common symptoms at the illness onset, it was reported to be more common among ICU patients.[3]
  • On March 11th, 2020, WHO declared the COVID-19 outbreak a pandemic.[4]
  • With the increasing evidence and ongoing research, anorexia associated with COVID-19 is now reported to be a common symptom among patients with COVID-19, and the viral infection is suspected in a patient presenting with anorexia along with other gastrointestinal symptoms.

Classification

There is no established system for the classification of anorexia in COVID-19.

Pathophysiology

Causes

COVID-19 associated anorexia may be classified according to the COVID-19 associated entity causing the symptom:

Differentiating COVID-19 associated anorexia from other Diseases

  • For further information regarding the differential diagnosis, click here.
  • To view the differential diagnosis of COVID-19, click here

Epidemiology and Demographics

  • According to WHO the prevalence of anorexia associated with COVID-19 is 40-84%.[18]
  • The pooled prevalence of COVID-19 associated anorexia is 21% according to a systematic review and meta-analysis based on the studies worldwide published between January 1st, 2020, and April 4th, 2020.[19]
  • The pooled prevalence of COVID-19 associated anorexia in Hong Kong is approximately 26.8%. The information is presented in a meta-analysis from the cohort of COVID-19 patients from Hong Kong (N = 59, from February 2 through February 29, 2020). 25% of the patients had GI symptoms associated with COVID-19.[20]
  • According to recent reviews and meta-analyses of COVID-19, patients from different parts of the world (China, Hong Kong) anorexia is the most common (40-84%) digestive symptoms associated with COVID-19.[21][19][20]
  • A retrospective study from Wuhna, China describing 1,141 cases of COVID-19 reported loss of appetite in 98% patients (n=180). Anorexia was the most common presenting symptom among all GI symptoms of COVID-19.[22]

Age

  • There is insufficient data to support an age group that is affected to a greater extent from COVID-19 associated anorexia.

Gender

Men more commonly presented with GI symptoms with anorexia being the most common symptom in Wuhan, China according to a retrospective study involving 1,141 cases of COVID-19.[22]

Race

  • There is no racial predilection for COVID-19 associated anorexia according to a systematic review and meta-analysis of observational studies on 12,797 patients. The meta-analysis compared Chinese race (Chinese group) from all other races (non-Chinese group) as the data from China makes a major part of COVID-19 related literature.[23]

Risk Factors

  • The most potent risk factor for the development of anorexia associated with COVID-19 is the infection COVID-19 itself.
  • Other risk factors involved in the process COVID-19 infected people presenting with anorexia have yet to be understood.

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

  • History of contact with a person suspected or confirmed to have COVID-19 infection is important to suspect COVID-19 in a patient.
  • Anorexia is itself a symptom. Based on a retrospective observational study including 1,141 cases of COVID-19 from Wuhan, China anorexia was the most common gastrointestinal symptom of COVID-19.[22]
  • The most common accompanying symptoms of COVID-19 besides anorexia were nausea, vomiting, and diarrhea.[26]
  • The timing of symptoms and presence of co-morbid conditions helps differentiate the diseases with similar symptoms.

Physical Examination

Physical examination may be remarkable for:

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

  • Abdominal CT scan may be helpful in finding the cause of COVID-19 associated anorexia.
  • Findings on CT scan suggestive of gastrointestinal symptoms (anorexia one of them) associated with COVID-19 infection include peri-intestinal inflammatory reaction.[28]
  • The CT scan findings in COVID-19 can be viewed by clicking here.

MRI

Other Imaging Findings

  • Bedside lung ultrasound may be helpful in the diagnosis of COVID-19 infection.
  • Other Imaging findings in bedside lung ultrasound to detect the signs of respiratory COVID-19 infection even when there are no respiratory symptoms.[28]

Treatment

Medical Therapy

Primary Prevention

  • Effective measures for the primary prevention of COVID-19 include::[46]
    • Frequent hand-washing with soap and water for at least 20 seconds or using a alcohol based hand sanitizer with at least 60% alcohol. Alcohol means ethanol here not methanol/ wood alcohol, as FDA warns against the use of methanol containing hand-wash.[47]
    • Staying at least 6 feet (approximately 2 arms’ length) from other individuals who do not live with you.
    • Covering your mouth and nose with a cloth face cover when around others and covering sneezes and coughs.
    • Cleaning and disinfecting.

Secondary prevention

  • Effective measures for the secondary prevention of COVID-19 include:
    • Use of personal protective equipment (PPE) by the personnel handling the fecal matter or visiting the patient. Protective eyewear (such as goggles or a face shield) used by healthcare personnel should cover the front and sides of the face with no gaps between glasses and the face.[48].
    • Screening of fecal microbiota transplant donors for COVID-19 is also recommended.[49]
    • Contact tracing helps reduce the spread of the disease.[50]
  • Oncologists from Wright State University OH, USA suggest fellow oncologists reconsider the routine use of prophylactic dexamethasone as an antiemetic among [cancer patients who are not infected with [COVID-19]]. As reported in several studies, higher lymphocyte level may be associated with better outcomes in COVID-19, avoiding dexamethasone will help avoid inducing lymphopenia.[51]

References

  1. 1.0 1.1 1.2 "www.who.int" (PDF).
  2. "Coronavirus (COVID-19) frequently asked questions | CDC".
  3. 3.0 3.1 3.2 Wang, Dawei; Hu, Bo; Hu, Chang; Zhu, Fangfang; Liu, Xing; Zhang, Jing; Wang, Binbin; Xiang, Hui; Cheng, Zhenshun; Xiong, Yong; Zhao, Yan; Li, Yirong; Wang, Xinghuan; Peng, Zhiyong (2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China". JAMA. 323 (11): 1061. doi:10.1001/jama.2020.1585. ISSN 0098-7484.
  4. "WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020".
  5. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S (April 2020). "Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study". Eur Arch Otorhinolaryngol. doi:10.1007/s00405-020-05965-1. PMC 7134551 Check |pmc= value (help). PMID 32253535 Check |pmid= value (help).
  6. 6.0 6.1 Kanra GY, Ozen H, Kara A (2006). "Infection and anorexia". Turk. J. Pediatr. 48 (4): 279–87. PMID 17290560.
  7. 7.0 7.1 Langhans W, Hrupka B (October 1999). "Interleukins and tumor necrosis factor as inhibitors of food intake". Neuropeptides. 33 (5): 415–24. doi:10.1054/npep.1999.0048. PMID 10657519.
  8. Chu H, Chan JF, Wang Y, Yuen TT, Chai Y, Hou Y, Shuai H, Yang D, Hu B, Huang X, Zhang X, Cai JP, Zhou J, Yuan S, Kok KH, To KK, Chan IH, Zhang AJ, Sit KY, Au WK, Yuen KY (April 2020). "Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19". Clin. Infect. Dis. doi:10.1093/cid/ciaa410. PMC 7184390 Check |pmc= value (help). PMID 32270184 Check |pmid= value (help).
  9. Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M (June 2020). "The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system". Cytokine Growth Factor Rev. 53: 25–32. doi:10.1016/j.cytogfr.2020.05.003. PMC 7211650 Check |pmc= value (help). PMID 32446778 Check |pmid= value (help).
  10. Zou, Xin; Chen, Ke; Zou, Jiawei; Han, Peiyi; Hao, Jie; Han, Zeguang (2020). "Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection". Frontiers of Medicine. 14 (2): 185–192. doi:10.1007/s11684-020-0754-0. ISSN 2095-0217.
  11. 11.0 11.1 Laviano A, Cangiano C, Preziosa I, Riggio O, Conversano L, Cascino A, Ariemma S, Rossi Fanelli F (March 1997). "Plasma tryptophan levels and anorexia in liver cirrhosis". Int J Eat Disord. 21 (2): 181–6. doi:10.1002/(sici)1098-108x(199703)21:2<181::aid-eat9>3.0.co;2-h. PMID 9062842.
  12. Zhang F, Shen A, Jin Y, Qiang W (August 2018). "The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews". BMC Complement Altern Med. 18 (1): 236. doi:10.1186/s12906-018-2304-8. PMC 6085669. PMID 30092794.
  13. Wang, Yeming; Zhang, Dingyu; Du, Guanhua; Du, Ronghui; Zhao, Jianping; Jin, Yang; Fu, Shouzhi; Gao, Ling; Cheng, Zhenshun; Lu, Qiaofa; Hu, Yi; Luo, Guangwei; Wang, Ke; Lu, Yang; Li, Huadong; Wang, Shuzhen; Ruan, Shunan; Yang, Chengqing; Mei, Chunlin; Wang, Yi; Ding, Dan; Wu, Feng; Tang, Xin; Ye, Xianzhi; Ye, Yingchun; Liu, Bing; Yang, Jie; Yin, Wen; Wang, Aili; Fan, Guohui; Zhou, Fei; Liu, Zhibo; Gu, Xiaoying; Xu, Jiuyang; Shang, Lianhan; Zhang, Yi; Cao, Lianjun; Guo, Tingting; Wan, Yan; Qin, Hong; Jiang, Yushen; Jaki, Thomas; Hayden, Frederick G; Horby, Peter W; Cao, Bin; Wang, Chen (2020). "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial". The Lancet. 395 (10236): 1569–1578. doi:10.1016/S0140-6736(20)31022-9. ISSN 0140-6736.
  14. Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, Ferrara C, Libroia A, Ragone G, Ioio CD, Savastano B, Polverino M, De Falco F, Iaccarino S, Leo E (August 2020). "COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature". Crit. Rev. Oncol. Hematol. 152: 102991. doi:10.1016/j.critrevonc.2020.102991. PMC 7239789 Check |pmc= value (help). PMID 32544802 Check |pmid= value (help).
  15. 15.0 15.1 15.2 Hadi A, Werge M, Kristiansen KT, Pedersen UG, Karstensen JG, Novovic S, Gluud LL (June 2020). "Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members". Pancreatology. 20 (4): 665–667. doi:10.1016/j.pan.2020.04.021. PMC 7199002 Check |pmc= value (help). PMID 32387082 Check |pmid= value (help).
  16. Yau YH, Potenza MN (September 2013). "Stress and eating behaviors". Minerva Endocrinol. 38 (3): 255–67. PMC 4214609. PMID 24126546.
  17. Takeda E, Terao J, Nakaya Y, Miyamoto K, Baba Y, Chuman H, Kaji R, Ohmori T, Rokutan K (August 2004). "Stress control and human nutrition". J. Med. Invest. 51 (3–4): 139–45. doi:10.2152/jmi.51.139. PMID 15460899.
  18. "WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard".
  19. 19.0 19.1 19.2 Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH (July 2020). "Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis". Lancet Gastroenterol Hepatol. 5 (7): 667–678. doi:10.1016/S2468-1253(20)30126-6. PMC 7217643 Check |pmc= value (help). PMID 32405603 Check |pmid= value (help).
  20. 20.0 20.1 Cheung KS, Hung I, Chan P, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung T, Tam AR, Yip C, Leung KH, Fung AY, Zhang RR, Lin Y, Cheng HM, Zhang A, To K, Chan KH, Yuen KY, Leung WK (April 2020). "Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis". Gastroenterology. doi:10.1053/j.gastro.2020.03.065. PMC 7194936 Check |pmc= value (help). PMID 32251668 Check |pmid= value (help). Vancouver style error: initials (help)
  21. "Management of Patients with Confirmed 2019-nCoV | CDC".
  22. 22.0 22.1 22.2 Luo S, Zhang X, Xu H (June 2020). "Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)". Clin. Gastroenterol. Hepatol. 18 (7): 1636–1637. doi:10.1016/j.cgh.2020.03.043. PMC 7154217 Check |pmc= value (help). PMID 32205220 Check |pmid= value (help).
  23. Tariq, Raseen; Saha, Srishti; Furqan, Fateeha; Hassett, Leslie; Pardi, Darrell; Khanna, Sahil (2020). "Prevalence and Mortality of COVID-19 patients with Gastrointestinal Symptoms: A Systematic Review and Meta-analysis". Mayo Clinic Proceedings. doi:10.1016/j.mayocp.2020.06.003. ISSN 0025-6196.
  24. Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, Gu Z, Gao L, Shi H, Mai L, Liu Y, Lin X, Lai R, Yan Z, Li X, Shan H (June 2020). "Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection". Gut. 69 (6): 997–1001. doi:10.1136/gutjnl-2020-321013. PMC 7316116 Check |pmc= value (help). PMID 32241899 Check |pmid= value (help).
  25. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, Jin Y, Niu X, Ping R, Du Y, Li T, Xu G, Hu Q, Tu L (May 2020). "Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study". Am. J. Gastroenterol. 115 (5): 766–773. doi:10.14309/ajg.0000000000000620. PMC 7172492 Check |pmc= value (help). PMID 32287140 Check |pmid= value (help).
  26. 26.0 26.1 Mao, Ren; Qiu, Yun; He, Jin-Shen; Tan, Jin-Yu; Li, Xue-Hua; Liang, Jie; Shen, Jun; Zhu, Liang-Ru; Chen, Yan; Iacucci, Marietta; Ng, Siew C; Ghosh, Subrata; Chen, Min-Hu (2020). "Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis". The Lancet Gastroenterology & Hepatology. 5 (7): 667–678. doi:10.1016/S2468-1253(20)30126-6. ISSN 2468-1253.
  27. Telias, Irene; Katira, Bhushan H.; Brochard, Laurent (2020). "Is the Prone Position Helpful During Spontaneous Breathing in Patients With COVID-19?". JAMA. 323 (22): 2265. doi:10.1001/jama.2020.8539. ISSN 0098-7484.
  28. 28.0 28.1 28.2 28.3 28.4 28.5 Poggiali E, Ramos PM, Bastoni D, Vercelli A, Magnacavallo A (2020). "Abdominal Pain: A Real Challenge in Novel COVID-19 Infection". Eur J Case Rep Intern Med. 7 (4): 001632. doi:10.12890/2020_001632. PMC 7162568 Check |pmc= value (help). PMID 32309266 Check |pmid= value (help).
  29. Guan, Wei-jie; Ni, Zheng-yi; Hu, Yu; Liang, Wen-hua; Ou, Chun-quan; He, Jian-xing; Liu, Lei; Shan, Hong; Lei, Chun-liang; Hui, David S.C.; Du, Bin; Li, Lan-juan; Zeng, Guang; Yuen, Kwok-Yung; Chen, Ru-chong; Tang, Chun-li; Wang, Tao; Chen, Ping-yan; Xiang, Jie; Li, Shi-yue; Wang, Jin-lin; Liang, Zi-jing; Peng, Yi-xiang; Wei, Li; Liu, Yong; Hu, Ya-hua; Peng, Peng; Wang, Jian-ming; Liu, Ji-yang; Chen, Zhong; Li, Gang; Zheng, Zhi-jian; Qiu, Shao-qin; Luo, Jie; Ye, Chang-jiang; Zhu, Shao-yong; Zhong, Nan-shan (2020). "Clinical Characteristics of Coronavirus Disease 2019 in China". New England Journal of Medicine. 382 (18): 1708–1720. doi:10.1056/NEJMoa2002032. ISSN 0028-4793.
  30. Olry A, Meunier L, Délire B, Larrey D, Horsmans Y, Le Louët H (July 2020). "Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same". Drug Saf. 43 (7): 615–617. doi:10.1007/s40264-020-00954-z. PMC 7279629 Check |pmc= value (help). PMID 32514859 Check |pmid= value (help).
  31. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T (June 2020). "Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper". JHEP Rep. 2 (3): 100113. doi:10.1016/j.jhepr.2020.100113. PMC 7128473 Check |pmc= value (help). PMID 32289115 Check |pmid= value (help).
  32. 32.0 32.1 Abdalhadi A, Alkhatib M, Mismar AY, Awouda W, Albarqouni L (2020). "Can COVID 19 present like appendicitis?". IDCases. 21: e00860. doi:10.1016/j.idcr.2020.e00860. PMC 7265835 Check |pmc= value (help). PMID 32523872 Check |pmid= value (help).
  33. "CDC's Diagnostic Test for COVID-19 Only and Supplies | CDC".
  34. Chen D, Li X, Song Q, Hu C, Su F, Dai J, Ye Y, Huang J, Zhang X (June 2020). "Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China". JAMA Netw Open. 3 (6): e2011122. doi:10.1001/jamanetworkopen.2020.11122. PMC 7290402 Check |pmc= value (help). PMID 32525548 Check |pmid= value (help).
  35. Alfano, Gaetano; Ferrari, Annachiara; Fontana, Francesco; Perrone, Rossella; Mori, Giacomo; Ascione, Elisabetta; Riccardo, Magistroni; Venturi, Giulia; Pederzoli, Simone; Margiotta, Gianluca; Romeo, Marilina; Piccinini, Francesca; Franceschi, Giacomo; Volpi, Sara; Faltoni, Matteo; Ciusa, Giacomo; Bacca, Erica; Tutone, Marco; Raimondi, Alessandro; menozzi, marianna; Franceschini, Erica; Cuomo, Gianluca; Orlando, Gabriella; Santoro, Antonella; Di Gaetano, Margherita; Puzzolante, Cinzia; Carli, Federica; Bedini, Andrea; Milic, Jovana; Meschiari, Marianna; Mussini, Cristina; Cappelli, Gianni; Guaraldi, Giovanni (2020). doi:10.1101/2020.06.14.20131169. Missing or empty |title= (help)
  36. Wang, Fan; Wang, Haizhou; Fan, Junli; Zhang, Yongxi; Wang, Hongling; Zhao, Qiu (2020). "Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia". Gastroenterology. 159 (1): 367–370. doi:10.1053/j.gastro.2020.03.055. ISSN 0016-5085.
  37. Aloysius MM, Thatti A, Gupta A, Sharma N, Bansal P, Goyal H (May 2020). "COVID-19 presenting as acute pancreatitis". Pancreatology. doi:10.1016/j.pan.2020.05.003. PMC 7207100 Check |pmc= value (help). PMID 32444169 Check |pmid= value (help).
  38. 38.0 38.1 Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvarà S, Lucarini S, Busoni S, Mazzoni LN, Miele V (August 2020). "Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome". Radiol Med. 125 (8): 730–737. doi:10.1007/s11547-020-01232-9. PMC 7282464 Check |pmc= value (help). PMID 32519256 Check |pmid= value (help).
  39. Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; Ruan, Lianguo; Song, Bin; Cai, Yanping; Wei, Ming; Li, Xingwang; Xia, Jiaan; Chen, Nanshan; Xiang, Jie; Yu, Ting; Bai, Tao; Xie, Xuelei; Zhang, Li; Li, Caihong; Yuan, Ye; Chen, Hua; Li, Huadong; Huang, Hanping; Tu, Shengjing; Gong, Fengyun; Liu, Ying; Wei, Yuan; Dong, Chongya; Zhou, Fei; Gu, Xiaoying; Xu, Jiuyang; Liu, Zhibo; Zhang, Yi; Li, Hui; Shang, Lianhan; Wang, Ke; Li, Kunxia; Zhou, Xia; Dong, Xuan; Qu, Zhaohui; Lu, Sixia; Hu, Xujuan; Ruan, Shunan; Luo, Shanshan; Wu, Jing; Peng, Lu; Cheng, Fang; Pan, Lihong; Zou, Jun; Jia, Chunmin; Wang, Juan; Liu, Xia; Wang, Shuzhen; Wu, Xudong; Ge, Qin; He, Jing; Zhan, Haiyan; Qiu, Fang; Guo, Li; Huang, Chaolin; Jaki, Thomas; Hayden, Frederick G.; Horby, Peter W.; Zhang, Dingyu; Wang, Chen (2020). "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19". New England Journal of Medicine. 382 (19): 1787–1799. doi:10.1056/NEJMoa2001282. ISSN 0028-4793.
  40. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ (February 2020). "Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR". J. Korean Med. Sci. 35 (6): e79. doi:10.3346/jkms.2020.35.e79. PMC 7025910 Check |pmc= value (help). PMID 32056407 Check |pmid= value (help).
  41. 41.0 41.1 41.2 Nicola M, O'Neill N, Sohrabi C, Khan M, Agha M, Agha R (May 2020). "Evidence based management guideline for the COVID-19 pandemic - Review article". Int J Surg. 77: 206–216. doi:10.1016/j.ijsu.2020.04.001. PMC 7151371 Check |pmc= value (help). PMID 32289472 Check |pmid= value (help).
  42. Khanna S, Pardi DS (November 2012). "Clostridium difficile infection: new insights into management". Mayo Clin. Proc. 87 (11): 1106–17. doi:10.1016/j.mayocp.2012.07.016. PMC 3541870. PMID 23127735.
  43. Queiroz N, Barros LL, Azevedo M, Oba J, Sobrado CW, Carlos AS, Milani LR, Sipahi AM, Damião A (2020). "Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance". Clinics (Sao Paulo). 75: e1909. doi:10.6061/clinics/2020/e1909. PMC 7153358 Check |pmc= value (help). PMID 32321117 Check |pmid= value (help). Vancouver style error: initials (help)
  44. Su, Song; Shen, Jun; Zhu, Liangru; Qiu, Yun; He, Jin-Shen; Tan, Jin-Yu; Iacucci, Marietta; Ng, Siew C; Ghosh, Subrata; Mao, Ren; Liang, Jie (2020). "Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges". Therapeutic Advances in Gastroenterology. 13: 175628482093462. doi:10.1177/1756284820934626. ISSN 1756-2848.
  45. "NIH clinical trial of investigational vaccine for COVID-19 begins | National Institutes of Health (NIH)".
  46. "How to Protect Yourself & Others | CDC".
  47. "Coronavirus (COVID-19) Update: FDA Takes Action to Warn, Protect Consumers from Dangerous Alcohol-Based Hand Sanitizers Containing Methanol | FDA".
  48. "Infection Control: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | CDC".
  49. Green CA, Quraishi MN, Shabir S, Sharma N, Hansen R, Gaya DR, Hart AL, Loman NJ, Iqbal TH (June 2020). "Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward". Lancet Gastroenterol Hepatol. 5 (6): 531. doi:10.1016/S2468-1253(20)30089-3. PMC 7225406 Check |pmc= value (help). PMID 32240618 Check |pmid= value (help).
  50. "Contact Tracing for COVID-19 | CDC".
  51. Marinella MA (June 2020). "Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider?". J Oncol Pharm Pract: 1078155220931921. doi:10.1177/1078155220931921. PMID 32507102 Check |pmid= value (help).

Template:WS Template:WH